KONECT

RESILIA Aortic Valved Conduit

 

Resilient tissue.
Ready to go.

 
 

Designed with quality performance in mind

The KONECT RESILIA aortic valved conduit brings together advanced tissue technology with the proven performance of an established valve platform. The result is the first pre-assembled, ready-to-go* valved conduit with RESILIA tissue.

*Consult instructions for use for device preparation instructions.

 

†RESILIA tissue tested against commercially available bovine pericardial tissue from Edwards in a juvenile sheep model.1

 

No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.

Consistent with Edwards Lifesciences' other valve products, the KONECT RESILIA aortic valved conduit underwent a very robust design and development process. Come take a closer look and go behind the scenes at Edwards Lifesciences to see how the KONECT RESILIA aortic valved conduit is made.

Watch the manufacturing video

Brochures for you and your patients are also available to download 

Want to learn more? Visit the KONECT product page for additional details, animations, and specifications.

References

  1. Flameng W, et al. A randomized assessment of an advanced tissue preservation technology in the juvenile sheep model. J Thorac Cardiovasc Surg. 2015;149:340–5.

Important Safety Information

KONECT RESILIA Aortic Valved Conduit

 

Indications:
For use in replacement of native or prosthetic aortic heart valves and associated repair or replacement of a damaged or diseased ascending aorta. 

 

Contraindications:

There are no known contraindications with the use of the KONECT RESILIA aortic valved conduit.

 

Complications and Side Effects:

Thromboembolism, valve thrombosis, hemorrhage, hemolysis, regurgitation, endocarditis, structural valve deterioration, nonstructural dysfunction, stenosis, arrhythmia, transient ischemic attack/stroke, congestive heart failure, myocardial infarction, any of which could lead to reoperation, explantation, permanent disability, and death. Adverse events potentially associated with the use of polyester vascular grafts include hemorrhage, thrombosis, graft infection, embolism, aneurysm, pseudoaneurysm, seroma, occlusion (anastomotic intimal hyperplasia), immunological reaction to collagen (shown to be a weak immunogen; infrequent, mild, localized and self-limiting), intimal peel formation, and conduit dilatation.

 

CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information.